세계의 치료제 모니터링 시장 - 산업 규모, 점유율, 동향, 기회, 예측, 약제 클래스별, 기술별, 지역별, 경쟁(2020-2030년)
Therapeutic Drug Monitoring Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class, By Technology, By Region and Competition, 2020-2030F
상품코드:1763911
리서치사:TechSci Research
발행일:2025년 06월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 치료제 모니터링 시장은 2024년에 15억 달러로 평가되었으며, 2030년에는 18억 2,000만 달러에 이르고, CAGR 3.47%를 나타낼 것으로 예측됩니다.
치료제 모니터링(TDM)은 Precision Medicine의 중요한 요소로, 임상의가 혈류 중 약물 농도를 측정하고 최적의 안전성과 효능을 얻기 위해 치료를 조정할 수 있습니다. TDM은 치료 영역이 좁은 약물과 개인에 따라 신진 대사가 다른 약물에 특히 중요합니다. 특히 면역억제제, 항생제, 항간질제 등의 장기 치료를 받고 있는 환자는 부작용을 피하면서 치료 효과를 유지하기 위해 빈번한 모니터링이 필요합니다. 이러한 수요가 있음에도 불구하고, 시장에는 장비의 고비용, 전문 지식의 필요성, 자원의 제약이나 인지도의 낮음에 의한 신흥국 시장에서의 채용의 제한과 같은 장애물이 존재합니다.
The Global Therapeutic Drug Monitoring Market was valued at USD 1.50 Billion in 2024 and is projected to reach USD 1.82 Billion by 2030, expanding at a CAGR of 3.47%. Therapeutic Drug Monitoring (TDM) is a critical component of precision medicine, enabling clinicians to measure drug levels in the bloodstream to tailor treatment for optimal safety and efficacy. TDM is particularly important for medications with narrow therapeutic windows or variable metabolism across individuals. With rising incidences of chronic conditions such as epilepsy, cancer, and cardiovascular and autoimmune diseases, the need for routine drug monitoring is becoming more pronounced. Patients undergoing long-term treatments-especially with immunosuppressants, antibiotics, or antiepileptic drugs-require frequent monitoring to maintain therapeutic effectiveness while avoiding adverse effects. Despite this demand, the market encounters hurdles, such as the high cost of equipment, the need for technical expertise, and limited adoption in developing regions due to resource constraints and low awareness.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 1.50 Billion
Market Size 2030
USD 1.82 Billion
CAGR 2025-2030
3.47%
Fastest Growing Segment
Antiepileptic Drug
Largest Market
North America
Key Market Drivers
Growth in Healthcare Industry
The ongoing expansion of the global healthcare sector, with annual revenues exceeding USD 4 trillion, is a key catalyst for the therapeutic drug monitoring market. Pharmaceuticals and biotechnology contribute nearly USD 850 billion, while medical technology and diagnostics generate over USD 400 billion. As healthcare systems worldwide evolve toward precision-driven, patient-centric models, TDM is gaining importance for its ability to optimize treatment efficacy and minimize adverse drug reactions. Growing emphasis on individualized therapy and safe medication practices positions TDM as an integral part of modern clinical care protocols.
Key Market Challenges
High Cost of Testing and Infrastructure
The substantial cost associated with implementing and maintaining TDM capabilities represents a significant challenge for broader adoption. Establishing a dedicated TDM facility necessitates advanced instruments such as liquid chromatography-mass spectrometry (LC-MS), immunoassay analyzers, and robust data management systems. These high capital investments are coupled with recurring expenses related to maintenance, quality control, and skilled labor. Additionally, compliance with stringent regulatory and quality standards further escalates the cost of infrastructure. These barriers are particularly restrictive for smaller healthcare facilities and institutions in developing economies.
Key Market Trends
Rising Demand for Personalized Medicine
A major trend shaping the TDM market is the increasing adoption of personalized medicine, valued globally at approximately USD 512 billion in 2022. Personalized medicine aims to deliver treatments tailored to an individual's genetic profile, lifestyle, and physiological response. In this context, TDM serves as a vital enabler by allowing healthcare professionals to monitor drug concentrations in real-time, ensuring therapeutic levels are achieved without toxicity. This is especially crucial for drugs with narrow therapeutic indices. The convergence of TDM with pharmacogenomics and precision diagnostics is reinforcing its role in developing more accurate, patient-specific treatment regimens, ultimately enhancing clinical outcomes.
Key Market Players
Roche AG
Siemens Healthcare GmbH
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Beckman Coulter, Inc.
Abbott Laboratories, Inc.
Agilent Technologies, Inc.
bioMerieux, Inc.
Alere, Inc.
Report Scope
In this report, the Global Therapeutic Drug Monitoring Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Therapeutic Drug Monitoring Market, By Drug Class:
Antiepileptic Drug
Antibiotic Drug
Immunosuppressant Drug
Antiarrhythmic Drug
Bronchodilator Drug
Psychoactive Drug
Others
Therapeutic Drug Monitoring Market, By Technology:
Immunoassay
Chemiluminescence Immunoassay
Colorimetric Immunoassay
Fluorescence Immunoassay
Radioimmunoassay
Others
Therapeutic Drug Monitoring Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Therapeutic Drug Monitoring Market.
Available Customizations
Global Therapeutic Drug Monitoring Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Impact of COVID-19 on Global Therapeutic Drug Monitoring Market
5. Global Therapeutic Drug Monitoring Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Class (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, Others)
